ZIOP:ZIOPHARM Oncology Inc - Stock Price Quote and Dividend Data
ZIOP STOCK PRICE LATEST CLOSE
$0.87
EXCHANGE
NASDAQ
SECTOR / SEGMENT / INDUSTRY
Health Care / Pharmaceuticals & Biotechnology / Pharmaceuticals
ZIOPHARM Oncology Inc Dividend Information
Trailing 12 Month Dividend YieldN/A
Projected 10 Year Dividend Yield0.00%
Dividend Yield 5 Year Average0.00%
Dividend Rate (IAD)$0.00
Dividend Payout Ratio0.00%
Dividend Payout Ratio 5 yr Average0.00%
Dividend Growth Rate 3 yr Average0.00%
Dividend Growth Rate 5 yr Average0.00%
Dividend AllStar™ Ranking
Consecutive Dividend Increases0 Years
Dividend Declaration DateNone
Dividend Ex DateNone
Dividend Record DateNone
Dividend Pay DateNone
Dividend Amount Current$0.000
Dividend Amount Previous$0.000
Dividends Paid in the Last 12 Months0
First Dividend Paid1970
ZIOPHARM Oncology Inc Stock Price Information
52-Week Low/High Stock Price$0.77 - $5.95
Percent Held by Institutions52.52%
Revenue$796,000
Net Income$-112,462,000
Cash Flow$-9,577,000
EPS-0.11%
Market Cap$187,117,592
PE Ratio0
PE Ratio to Industry58%
Debt-Equity Ratio35.24%
Debt-Equity to Industry1.36%
Total Return Last 12 Months-75.61%
Total Return Last 3 Years-59.17%
Total Return Last 5 Years-84.20%
Latest Trade DateJan. 26, 2022
ZIOPHARM Oncology Inc Annual Stock Dividends
No Data available for Payment History.
ZIOPHARM Oncology Inc Dividend Payment History
| No dividends retrieved for ZIOP |
ZIOPHARM Oncology Inc Other Dividend Details
ZIOPHARM Oncology is a biopharmaceutical company focused on discovering, developing and commercializing immuno-oncology platforms that utilize cell- and gene-based therapies to treat patients with cancer. Co.'s primary platform is referred to as Sleeping Beauty and is based on the non-viral genetic engineering of immune cells using a transposon/transposase system that is intended to stably engineer T cells outside of the body for subsequent infusion. Co.'s second platform is referred to as Controlled IL-12 and is designed to stimulate expression of interleukin 12, a master regulator of the immune system, in a controlled manner to focus the patient's immune system to attack cancer cells.
SectorHealth Care
SegmentPharmaceuticals & Biotechnology
IndustryPharmaceuticals
Dividend AllStar™ Ranking
Re-Investment AgentNone
Direct Purchase Minimum$0
Optional Cash Pay Min-Max$0 - $0
Optional Cash Payment FrequencyNone
Jan. 25, 2022ZIOP STOCK PRICE INCREASE: ZIOPHARM Oncology Inc on 01-25-2022 increased stock price > 10% from $0.82 to $0.92
Jan. 22, 2022ZIOP STOCK PRICE 52 WEEK LOW: ZIOPHARM Oncology Inc on 01-22-2022 hit a 52 week low of $0.82
Jan. 14, 2022ZIOP STOCK PRICE 52 WEEK LOW: ZIOPHARM Oncology Inc on 01-14-2022 hit a 52 week low of $0.88
Jan. 06, 2022ZIOP STOCK PRICE 52 WEEK LOW: ZIOPHARM Oncology Inc on 01-06-2022 hit a 52 week low of $1.01
Dec. 29, 2021ZIOP STOCK PRICE 52 WEEK LOW: ZIOPHARM Oncology Inc on 12-29-2021 hit a 52 week low of $1.11
Dec. 18, 2021ZIOP STOCK PRICE INCREASE: ZIOPHARM Oncology Inc on 12-18-2021 increased stock price > 10% from $1.18 to $1.35
Dec. 04, 2021ZIOP STOCK PRICE 52 WEEK LOW: ZIOPHARM Oncology Inc on 12-04-2021 hit a 52 week low of $1.22
Sep. 29, 2021ZIOP STOCK PRICE DECREASE: ZIOPHARM Oncology Inc on 09-29-2021 decreased stock price > 10% from $2.12 to $1.88
Sep. 24, 2021ZIOP STOCK PRICE INCREASE: ZIOPHARM Oncology Inc on 09-24-2021 increased stock price > 10% from $1.89 to $2.13
Sep. 15, 2021ZIOP STOCK PRICE DECREASE: ZIOPHARM Oncology Inc on 09-15-2021 decreased stock price > 10% from $1.82 to $1.63
Apr. 11, 2025NTHI STOCK PRICE DECREASE: NeOnc Technologies Holdings Inc on 04-11-2025 decreased stock price > 10% from $10.00 to $9.00
Apr. 11, 2025SION STOCK PRICE DECREASE: Sionna Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $8.88 to $7.66
Apr. 11, 2025MTSR STOCK PRICE DECREASE: Metsera Inc on 04-11-2025 decreased stock price > 10% from $15.27 to $13.08
Apr. 11, 2025CYTOF STOCK PRICE DECREASE: Altamira Therapeutics Ltd on 04-11-2025 decreased stock price > 10% from $0.09 to $0.06
Apr. 11, 2025DWTX STOCK PRICE DECREASE: Dogwood Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $3.30 to $2.94
Apr. 11, 2025TRVN STOCK PRICE DECREASE: Com Par $0.001/Trevena Inc on 04-11-2025 decreased stock price > 10% from $1.36 to $1.20
Apr. 11, 2025OSTX STOCK PRICE DECREASE: OS Therapies Inc on 04-11-2025 decreased stock price > 10% from $1.34 to $1.12
Apr. 11, 2025RGBPP STOCK PRICE DECREASE: Pfd Ser A (New)/Regen BioPharma Inc on 04-11-2025 decreased stock price > 10% from $0.06 to $0.05
Apr. 11, 2025ALMS STOCK PRICE DECREASE: Alumis Inc on 04-11-2025 decreased stock price > 10% from $8.04 to $6.83
Apr. 11, 2025CTNM STOCK PRICE DECREASE: Cl A/Contineum Therapeutics Inc on 04-11-2025 decreased stock price > 10% from $4.62 to $4.13
